Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508849 | SCV001715260 | uncertain significance | not provided | 2020-02-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003382621 | SCV004088664 | uncertain significance | Hereditary pancreatitis | 2023-07-29 | criteria provided, single submitter | clinical testing | The p.R29L variant (also known as c.86G>T), located in coding exon 2 of the CTRC gene, results from a G to T substitution at nucleotide position 86. The arginine at codon 29 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |